Position in ACB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$55,947
-$112,177 QoQ
Shares Held
20,053
-49.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 149 holders
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026State of Wyoming holds $8,248,921 across 35 Drug Manufacturers - Specialty & Generic names. ACB ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
13,691 | $717,408 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
10,326 | $660,347 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
13,100 | $619,237 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
58,264 | $582,640 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
28,930 | $500,778 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
17,609 | $433,357 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
101,781 | $428,498 | |
| 8 | VTRS |
Viatris Inc
|
26,837 | $426,171 |
All Filings in ACB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,947 | 20,053 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $168,124 | 39,840 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $100,581 | 23,722 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $94,279 | 21,476 | Shares | Sole | 2025-05-14 | |
| 2022-09-30 | $88,443 | 72,495 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||